Huntington National Bank’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-233
Closed -$3.02K 4175
2025
Q1
$3.02K Hold
233
﹤0.01% 2127
2024
Q4
$2.98K Sell
233
-62
-21% -$750 ﹤0.01% 2155
2024
Q3
$3.29K Sell
295
-2,496
-89% -$27.5K ﹤0.01% 2108
2024
Q2
$31.3K Buy
2,791
+2,541
+1,016% +$29.6K ﹤0.01% 1311
2024
Q1
$3.1K Buy
250
+217
+658% +$2.83K ﹤0.01% 2035
2023
Q4
$461 Buy
+33
New +$458 ﹤0.01% 2296

Other funds holding DVAX

Huntington National Bank's DVAX Position: Q2 2025 in Review

Huntington National Bank sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 233 shares — an estimated $3.02K sold.

Huntington National Bank first reported a position in DVAX in Q4 2023 and held it in 6 quarters. The position peaked at $31.3K in Q2 2024. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Huntington National Bank reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Huntington National Bank sold 233 Dynavax Technologies shares in Q2 2025, an estimated $3.02K.
  • Huntington National Bank first reported a position in Dynavax Technologies in Q4 2023 and held it in 6 quarters.
  • Huntington National Bank's Dynavax Technologies position peaked at $31.3K in Q2 2024.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Huntington National Bank's 13F filing for Q2 2025, filed 5 Aug 2025.